Association of the IRF5 risk haplotype with high serum interferon-alpha activity in systemic lupus erythematosus patients.
about
Nucleic Acid sensors and type I interferon production in systemic lupus erythematosusOverview of the biology of type I interferonsThe role of genetic variation near interferon-kappa in systemic lupus erythematosusSLE-associated risk factors affect DC functionIdentification of Candidate Predictors of Lupus FlareSelected Aspects in the Pathogenesis of Autoimmune DiseasesInflammatory cytokines in systemic lupus erythematosusImmune-regulatory mechanisms in systemic autoimmune and rheumatic diseasesModelling clinical systemic lupus erythematosus: similarities, differences and success storiesCause and consequences of the activated type I interferon system in SLEImmunological function of Blimp-1 in dendritic cells and relevance to autoimmune diseasesAdvances in lupus geneticsFamilial aggregation of autoimmune disease in juvenile dermatomyositisRecent advances in the genetics of autoimmune diseaseType I interferon signature is high in lupus and neuromyelitis optica but low in multiple sclerosisIRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with systemic lupus erythematosusEmerging therapies for systemic lupus erythematosus--focus on targeting interferon-alphaBrief Report: IRF5 systemic lupus erythematosus risk haplotype is associated with asymptomatic serologic autoimmunity and progression to clinical autoimmunity in mothers of children with neonatal lupusAssociation of the response to tumor necrosis factor antagonists with plasma type I interferon activity and interferon-beta/alpha ratios in rheumatoid arthritis patients: a post hoc analysis of a predominantly Hispanic cohortGene-gene-sex interaction in cytokine gene polymorphisms revealed by serum interferon alpha phenotype in juvenile dermatomyositisNetwork analysis of associations between serum interferon-α activity, autoantibodies, and clinical features in systemic lupus erythematosusDistinct regulation of murine lupus susceptibility genes by the IRF5/Blimp-1 axisLongitudinal expression of type I interferon responsive genes in systemic lupus erythematosus.Ribosomal and immune transcripts associate with relapse in acquired ADAMTS13-deficient thrombotic thrombocytopenic purpuraThe impact of vitamin D on dendritic cell function in patients with systemic lupus erythematosus.Genetic regulation of serum cytokines in systemic lupus erythematosusGenetic variation at the IRF7/PHRF1 locus is associated with autoantibody profile and serum interferon-alpha activity in lupus patientsGene network analysis of bone marrow mononuclear cells reveals activation of multiple kinase pathways in human systemic lupus erythematosus.Interferon-alpha: a therapeutic target in systemic lupus erythematosusA genomic approach to human autoimmune diseases.IFN regulatory factor 5 is required for disease development in the FcgammaRIIB-/-Yaa and FcgammaRIIB-/- mouse models of systemic lupus erythematosusType I interferon in the pathogenesis of lupus.Systemic sclerosis and lupus: points in an interferon-mediated continuum.The unexplained female predominance of systemic lupus erythematosus: clues from genetic and cytokine studies.Interferon alpha in systemic lupus erythematosusInterferon regulatory factor-5 deficiency ameliorates disease severity in the MRL/lpr mouse model of lupus in the absence of a mutation in DOCK2.mTOR signaling: a central pathway to pathogenesis in systemic lupus erythematosus?Trait-stratified genome-wide association study identifies novel and diverse genetic associations with serologic and cytokine phenotypes in systemic lupus erythematosus.Association of a functional polymorphism in the 3'-untranslated region of SPI1 with systemic lupus erythematosus.Gender-dependent expression of murine Irf5 gene: implications for sex bias in autoimmunity
P2860
Q21131202-0BF6635A-38C9-47AA-A515-B50E549AFD7DQ21195364-B5EDA1B3-9928-4B92-AFF1-C4360E643037Q21296846-FC124D9B-B7DF-451C-8D53-014192B9CFCFQ26774797-C0FD3886-2612-405F-B818-7198357E3C32Q26795372-370A10DC-5144-400E-983F-8AC11079E794Q26795580-D24A536D-00CF-44FB-BB9D-80AFC20EED27Q26823647-E7EBBF87-C3BB-405C-B6C1-E1FC8AC7D187Q26823714-FCE04E6D-C19A-4204-A8B6-3F6F67FC6414Q28074217-790E5B01-A63B-4D2C-90FC-C8EDAE033F69Q28075268-8D9AFCFC-BB51-4A1E-8D8B-1512A89A32EFQ28084887-0EBC55BC-F7D7-4A76-B704-A03E69AD1AF0Q28088718-2B985BA0-363C-4E64-8BAA-44A630DAAB97Q28235854-388B3897-27EB-4A17-9E4F-CD9E998B98C5Q28238782-BA44EE97-69AF-4586-9AC0-1577CABBDF72Q28251763-D960716C-490A-4DCC-B650-CE8A2A7CCB6DQ28253129-0795D9A1-7FA5-4C66-BEB0-5D402DA4F8DFQ28265144-867F1FC0-C34F-47DF-88A8-628DEBB8313EQ28268287-4CE5D012-CF3F-407F-9450-5EF9BDD15F25Q28271779-FDF7CE78-90EA-4BBA-BBCD-46A5EE6BEB59Q28287170-0B3BD19B-8F31-4B4F-92A0-27FC361DA35FQ28301151-41D1EBFB-1F1A-4BFD-B8A1-CDC022D5E332Q30423162-E6D1A40F-BFA1-4295-9ADC-8EE88F01536EQ30873883-B632528E-AB24-4F73-934F-D5C999DC7C76Q33420289-5E37136B-9591-485C-8BB8-6A09AEDEEB52Q33532591-502ACCCC-8D55-43E0-A62A-479C7F53135BQ33682879-F175CD18-2D06-423E-BB37-C8E8CD96CCABQ33703923-C772F3E6-4EAB-499F-9816-749A571EC7DBQ33728674-305AC8A4-5AD1-4283-9C5C-2A302B9A1653Q33744320-A0F58FA6-4A08-4031-8980-F7E549E4F36EQ33762839-0BC9F538-BA80-4238-B6C6-5884E4CB6F06Q33804141-8B0F6BAA-4C51-42FA-9F60-59E40D2E09A7Q33852174-745ADDC4-A9A4-40D8-BEC7-1ABAD8397357Q33889629-47E75458-9886-47CA-A6A5-7A916660F6D8Q33939981-28F6AE72-99DC-48E5-B940-CA7661A29502Q33961179-FF1F0298-D64B-4E36-98FC-299273E7A4ECQ33975488-E24E2C2E-8CDB-4ED3-B09E-F604CC5A1C44Q34107250-B08A2E39-89AA-4F4D-9FBB-58E5E1594FA7Q34153062-87131B99-0F3E-4185-A12F-59A233029620Q34167593-15821F17-83BB-4300-811F-9AE565C9845AQ34187236-EB5398EC-0450-46E8-815A-3B529D741090
P2860
Association of the IRF5 risk haplotype with high serum interferon-alpha activity in systemic lupus erythematosus patients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Association of the IRF5 risk h ...... lupus erythematosus patients.
@en
Association of the IRF5 risk h ...... lupus erythematosus patients.
@nl
type
label
Association of the IRF5 risk h ...... lupus erythematosus patients.
@en
Association of the IRF5 risk h ...... lupus erythematosus patients.
@nl
prefLabel
Association of the IRF5 risk h ...... lupus erythematosus patients.
@en
Association of the IRF5 risk h ...... lupus erythematosus patients.
@nl
P2093
P2860
P50
P356
P1476
Association of the IRF5 risk h ...... lupus erythematosus patients.
@en
P2093
Luis R Espinoza
Marie H Flesch
Mary K Crow
P2860
P304
P356
10.1002/ART.23613
P577
2008-08-01T00:00:00Z